Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects

被引:19
作者
Ahmed, Radwan H. [1 ]
Huri, Hasniza Zaman [2 ,3 ]
Al-Hamodi, Zaid [4 ]
Salem, Sameer D. [4 ]
Al-absi, Boshra [1 ]
Muniandy, Sekaran [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia
[3] Univ Malaya Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia
[4] Sanaa Univ, Dept Biochem & Mol Biol, Fac Med, Sanaa, Yemen
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
DIPEPTIDYL-PEPTIDASE-IV; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; RISK-FACTORS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; LINKING OBESITY; DISEASE; INFLAMMATION; INHIBITOR;
D O I
10.1371/journal.pone.0154369
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Genetic polymorphisms of the Dipeptidyl Peptidase 4 (DPP4) gene may play a role in the etiology of type 2 diabetes mellitus (T2DM). This study aimed to investigate the possible association of single nucleotide polymorphisms (SNPs) of the DPP4 gene in Malaysian subjects with T2DM and evaluated whether they had an effect on the serum levels of soluble dipeptidyl peptidase 4 (sDPP-IV). Method Ten DPP4 SNPs were genotyped by TaqMan genotyping assays in 314 subjects with T2DM and 235 controls. Of these, 71 metabolic syndrome (MetS) subjects were excluded from subsequent analysis. The odds ratios (ORs) and their 95% confidence interval (CIs) were calculated using multiple logistic regression for the association between the SNPs of DPP4 and T2DM. In addition, the serum levels of sDPP-IV were investigated to evaluate the association of the SNPs of DPP4 with the sDPP-IV levels. Results Dominant, recessive, and additive genetic models were employed to test the association of DPP4 polymorphisms with T2DM, after adjusting for age, race, gender and BMI. The rs12617656 was associated with T2DM in Malaysian subjects in the recessive genetic model (OR = 1.98, p = 0.006), dominant model (OR = 1.95, p = 0.008), and additive model (OR = 1.63, p = 0.001). This association was more pronounced among Malaysian Indians, recessive (OR = 3.21, p = 0.019), dominant OR = 3.72, p = 0.003) and additive model (OR = 2.29, p = 0.0009). The additive genetic model showed that DPP4 rs4664443 and rs7633162 polymorphisms were associated with T2DM (OR = 1.53, p = 0.039), and (OR = 1.42, p = 0.020), respectively. In addition, the rs4664443 G>A polymorphism was associated with increased sDPP-IV levels (p = 0.042) in T2DM subjects. Conclusions DPP4 polymorphisms were associated with T2DM in Malaysian subjects, and linked to variations in sDPP-IV levels. In addition, these associations were more pronounced among Malaysian Indian subjects.
引用
收藏
页数:12
相关论文
共 53 条
  • [1] Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis
    Aghili, Nima
    Devaney, Joseph M.
    Alderman, Lee O.
    Zukowska, Zofia
    Epstein, Stephen E.
    Burnett, Mary Susan
    [J]. NEUROPEPTIDES, 2012, 46 (06) : 367 - 371
  • [2] Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
    Ahmed, Radwan H.
    Huri, Hasniza Zaman
    Al-Hamodi, Zaid
    Salem, Sameer D.
    Muniandy, Sekaran
    [J]. PLOS ONE, 2015, 10 (10):
  • [3] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [4] Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI [10.2337/dc19-S002, 10.2337/dc18-S002, 10.2337/dc09-S062, 10.2337/dc12-S064]
  • [5] Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    Aschner, Pablo
    Kipnes, Mark S.
    Lunceford, Jared K.
    Sanchez, Matilde
    Mickel, Carolyn
    Williams-Herman, Debora E.
    [J]. DIABETES CARE, 2006, 29 (12) : 2632 - 2637
  • [6] Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI
    Bailey, Swneke D.
    Xie, Changchun
    Pare, Guillaume
    Montpetit, Alexandre
    Mohan, Viswanathan
    Yusuf, Salim
    Gerstein, Hertzel
    Engert, James C.
    Anand, Sonia S.
    [J]. DIABETOLOGIA, 2014, 57 (04) : 738 - 745
  • [7] Genetic Susceptibility to Type 2 Diabetes and Obesity: Follow-Up of Findings from Genome-Wide Association Studies
    Basile, Kevin J.
    Johnson, Matthew E.
    Xia, Qianghua
    Grant, Struan F. A.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [8] Diabetes mellitus and genetically programmed defects in β-cell function
    Bell, GI
    Polonsky, KS
    [J]. NATURE, 2001, 414 (6865) : 788 - 791
  • [9] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [10] Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals
    Bouchard, Luigi
    Faucher, Genevieve
    Tchernof, Andre
    Deshaies, Yves
    Lebel, Stefane
    Hould, Frederic-Simon
    Marceau, Picard
    Vohl, Marie-Claude
    [J]. ACTA DIABETOLOGICA, 2009, 46 (01) : 13 - 21